These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 898297)

  • 1. Regional chemotherapy of maxillofacial malignant melanoma with intracarotid artery infusion of DTIC.
    Jortay AM; Lejeune FJ; Kenis Y
    Tumori; 1977; 63(3):299-302. PubMed ID: 898297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracarotid artery infusion of DTIC for invasive maxillofacial melanoma.
    Lejeune FJ; Jortay AM; Dor P
    Recent Results Cancer Res; 1983; 86():162-4. PubMed ID: 6647995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of malignant melanoma. Results of a controlled clinical trial comparing vincristine + dacarbazin (DTIC) with and without duborimycin (author's transl)].
    Chauvergne J; Clavel B; Klein T; Pommatau E
    Bull Cancer; 1978; 65(2):107-9. PubMed ID: 359067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of high-dose hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma.
    Philip PA; Carmichael J; Tonkin K; Ganesan TA; Harris AL
    Eur J Cancer; 1994; 30A(7):1027-9. PubMed ID: 7946568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of malignant melanomas. Trial of D.T.I.C. by intra-arterial infusion].
    Banzet P; Ricbourg B; Jacquillat C; Dufourmentel C
    Nouv Presse Med; 1975 May; 4(20):1477-80. PubMed ID: 1215144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ; Falkson G
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypersensitivity to dacarbazine in patients with metastatic malignant melanoma].
    Levy A; Guitera P; Kerob D; Ollivaud L; Archimbaud A; Dubertret L; Basset-Seguin N
    Ann Dermatol Venereol; 2006 Feb; 133(2):157-60. PubMed ID: 16508601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful therapy of secondary melanoma of the orbit with DTIC].
    Ballin R; Lommatzsch PK; Klöppel R
    Klin Monbl Augenheilkd; 1987 Jul; 191(1):50-2. PubMed ID: 2443753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of disseminated malignant melanoma].
    Chauvergne J; Clavel B; Klein T; Pammatau E
    Nouv Presse Med; 1978 Sep; 7(30):2658-9. PubMed ID: 693309
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
    Thatcher D; Lind M; Morgenstern G; Carr T; Chadwick G; Jones R; Craig P
    Cancer; 1989 Apr; 63(7):1296-302. PubMed ID: 2646005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dacarbazine (DTIC) in malignant melanoma.
    Drug Ther Bull; 1976 May; 14(10):39-40. PubMed ID: 976088
    [No Abstract]   [Full Text] [Related]  

  • 12. [DTIC in malignant melanoma: a perspective (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr; 1978 Dec; 90(24):870-4. PubMed ID: 369152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
    Carmo-Pereira J; Oliveira Costa F; Pimentel P
    Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
    Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DTIC therapy in metastatic malignant melanoma: a simplified dose schedule.
    Pritchard KI; Quirt IC; Cowan DH; Osoba D; Kutas GJ
    Cancer Treat Rep; 1980; 64(10-11):1123-6. PubMed ID: 7459898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of malignant melanoma with dacarbazin (DTIC-DOME) with special reference to urinary excretion of 5-S-cysteinyldopa.
    Jönsson PE; Agrup G; Arnbjörnsson E; Hafström L; Rorsman H
    Cancer; 1980 Jan; 45(2):245-8. PubMed ID: 6153150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.
    Samson MK; Baker LH; Izbicki RM; Ratanatharathorn V
    Cancer Treat Rep; 1976 Sep; 60(9):1369-71. PubMed ID: 65223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea.
    Philip PA; Souliotis VL; Harris AL; Salisbury A; Tates AD; Mitchell K; van Delft JH; Ganesan TS; Kyrtopoulos SA
    Clin Cancer Res; 1996 Feb; 2(2):303-10. PubMed ID: 9816173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).
    Carbone PP; Costello W
    Cancer Treat Rep; 1976 Feb; 60(2):193-8. PubMed ID: 769973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma.
    Costanza ME; Nathanson L; Costello WG; Wolter J; Brunk SF; Colsky J; Hall T; Oberfield RA; Regelson W
    Cancer; 1976 Apr; 37(4):1654-9. PubMed ID: 769936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.